DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lawitz E, Landis CS, Flamm SL. et al.
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study.
The lancet Gastroenterology & hepatology 2020;
DOI: 10.1016/S2468-1253(19)30417-0.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.